Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Avadel Pharmaceuticals PLC as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- +18 vs. Q2 2025
- Shares held
- 80.0M
- −1.46M (−1.8%) vs. Q2 2025
- Total value
- $1.22B
- +$501.4M (+69.6%) vs. Q2 2025
- New holders
- 36
- 58 more added
- Sold out
- 18
- 61 more reduced
4 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVDL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $16 |
| Q1 2026 | 2 | $442 |
| Q4 2025 | 208 | $1.60B |
| Q3 2025 | 188 | $1.22B |
| Q2 2025 | 174 | $721.2M |
| Q1 2025 | 177 | $613.0M |
| Q4 2024 | 160 | $837.4M |
| Q3 2024 | 176 | $979.2M |
| Q2 2024 | 156 | $1.04B |
| Q1 2024 | 126 | $1.18B |
| Q4 2023 | 113 | $795.3M |
| Q3 2023 | 99 | $559.4M |
| Q2 2023 | 101 | $856.2M |
| Q1 2023 | 93 | $443.2M |
| Q4 2022 | 83 | $239.5M |
| Q3 2022 | 76 | $157.2M |
| Q2 2022 | 82 | $82.3M |
| Q1 2022 | 81 | $244.5M |
| Q4 2021 | 85 | $287.0M |
| Q3 2021 | 82 | $314.2M |
| Q2 2021 | 80 | $219.1M |
| Q1 2021 | 77 | $294.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Avadel Pharmaceuticals PLC; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Verition Fund Management LLC | 0 | $0 | 0.00% | −13,010−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −11,873−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −7,393−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −543−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Avantax Advisory Services, Inc. | – | – | – | – | Not filed |
| HAP Trading, LLC | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| First Horizon Advisors, Inc. | – | – | – | – | Not filed |